Creativity is an important human quality upon which many achievements of humankind are based. Defined as the ability to produce something that is novel and useful or meaningful, it is difficult to operationalize for research. This text provides an overview of the historical and cultural context of this research. The assumption that creativity is related to psychiatric vulnerability dates back to antiquity. The modern interest in the subject stems from the romantic era and gained a scientific aura in the 19th century. In the 20th century, a further entanglement of creativity and psychopathology came about through the influence of patient artists on regular art. Psychometric, psychodiagnostic and genetic research supports a connection between creativity and psychiatric illness within the bipolar-psychotic continuum, with schizotypy/thymotypy as prototypes of creativity-related disorders. Evolutionary hypotheses link the schizophrenia paradox to a survival advantage through enhanced creative ability. The relevance of scientific research in this complex and heterogeneous area can be increased if creativity and psychopathology are further operationalized and if underlying art concepts are made explicit and placed in a broader cultural context. There is a continuing need for meaningful definitions and measures, as well as a multidisciplinary collaboration.

1.
Glazer E: Rephrasing the madness and creativity debate: what is the nature of the creativity construct? Pers Individ Dif 2009;46:755-764.
2.
Batey M, Furnham A: Creativity, intelligence, and personality: a critical review of the scattered literature. Genet Soc Gen Psychol Monogr 2006;132:355-429.
3.
Goodnick PJ: Mania: Clinical and Research Perspectives. Washington, American Psychiatric Press, 1998.
4.
Késenne J: Het oorkussen van de melancholie. Gent, Museum voor Schone Kunsten Gent, 2000.
5.
Tollebeek J, Vanpaemel G, Wils K: Degeneratie in belgië (1860-1940). Leuven, Leuven University Press, 2004.
6.
Prinzhorn H: Bildnerei der Geisteskranken; ein Beitrag zur Psychologie und Psychopathologie der Gestaltung. Berlin, Verlag von Julius Springer, 1922.
7.
Sass LA: Madness and Modernism. New York, Basic Books, 1992.
8.
Dubuffet J: L'art brut préféré aux arts culturels. Paris, René Drouin, Compagnie de l'Art Brut, 1949.
9.
Cardinal R: Outsider Art. New York, Praeger, 1972.
10.
Szeeman H, Grüterich M, von den Velden K, Jennifer G-C: Documenta 5 1972. Kassel, documenta, 1972.
11.
Claridge G, Blakey S: Schizotypy and affective temperament: relationships with divergent thinking and creativity styles. Pers Individ Dif 2009;46:820-826.
12.
Dietrich A: The cognitive neuroscience of creativity. Psychon Bull Rev 2004;11:1011-1026.
13.
Andreasen NC: Creativity and mental illness: prevalence rates in writers and their first-degree relatives. Am J Psychiatry 1987;144:1288-1292.
14.
Andreasen NC: The Creating Brain. New York/Washington, The Dana Foundation, 2005.
15.
Kyaga S, Lichtenstein P, Boman M, Hultman C, Långstrøm N, Landén M: Creativity and mental disorder: family study of 300 000 people with severe mental disorder. Br J Psychiatry 2011;199:373-379.
16.
Folley BS: The cognitive neuroscience of creative thinking in the schizophrenia spectrum: individual differences, functional laterality and white matter connectivity; thesis, Nashville, Vanderbilt University, 2006, p 146.
17.
Post F: Creativity and psychopathology. A study of 291 world-famous men. Br J Psychiatry 1994;165:22-34.
18.
Pretz JE, Link JA: The creative task creator: a tool for the generation of customized, web-based creativity tasks. Behav Res Methods 2008;40:1129-1133.
19.
Nettle D: Schizotypy and mental health amongst poets, visual artists, and mathematicians. J Res Pers 2006;40:876-890.
20.
Van Os J, Kapur S: Schizophrenia. Lancet 2009;374:635-645.
21.
Rybakowski J, Klonowska P: Bipolar mood disorder, creativity and schizotypy: an experimental study. Psychopathology 2011;44:296-302.
22.
Thys E, Sabbe B, De Hert M: Creativiteit en psychiatrische stoornissen: recente neurowetenschappelijke inzichten. Tijdschr Psychiat 2011;53:905-915.
23.
Thys E: Kunst en het brein. Neuron 2007;12:383-391.
24.
Zeki S: Splendors and Miseries of the Brain: Love, Creativity and the Quest for Human Happiness. New York, Wiley-Blackwell, 2008.
25.
Zeki S: Splendours and miseries of the brain. Phil Trans R Soc Lond B Biol Sci 1999;354:2053-2065.
26.
Ramachandran V, Hirstein W: The science of art: a neurological theory of aesthetic experience. J Conscious Studies 1999;6:15-51.
27.
Van den Braembussche AA: Denken over kunst, een inleiding in de kunstfilosofie. Bussum, Coutinho, 2007.
28.
Barthes R: Le neutre. Cours au collège de France (1977-1978). Paris, Seuil, 2002.
29.
Nettle D, Clegg H: Schizotypy, creativity and mating success in humans. Proc Biol Sci 2006;273:611-615.
30.
Cela-Conde CJ, Lopez Arenillas C, Nadal M, Capo MA, Cortes Mascaro A, Marty G: Creativity and evolution. Int Congr Ser 2006;1296:95-105.
31.
Sacks O: Musicophilia: Tales of Music and the Brain. New York, Alfred A. Knopf, 2007.
32.
Nichols C: Is there an evolutionary advantage of schizophrenia? Pers Individ Dif 2009;46:832-838.
33.
Van Winkel R, Esquivel G, Kenis G, Wichers M, Collip D, Peerbooms O, Rutten B, Myin-Germeys I, Van Os J: Genome-wide findings in schizophrenia and the role of gene-environment interplay. CNS Neurosci Ther 2010;16:e185-e192.
34.
Reuter M, Roth S, Holve K, Hennig J: Identification of first candidate genes for creativity: a pilot study. Brain Res 2006;1069:190-197.
35.
Kéri S: Genes for psychosis and creativity: a promoter polymorphism of the neuregulin 1 gene is related to creativity in people with high intellectual achievement. Psychol Sci 2009;20:1070-1073.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.